These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1938268)
1. [Peculiarities of cardiac glycoside therapy in the aged]. Erdmann E Internist (Berl); 1991 Aug; 32(8):472-8. PubMed ID: 1938268 [No Abstract] [Full Text] [Related]
2. [Pharmacology of heart failure-relevant substance groups]. Scholz H Verh Dtsch Ges Inn Med; 1990; 96():150-6. PubMed ID: 2092434 [No Abstract] [Full Text] [Related]
3. [Indications, contra-indications and dosage of cardiac glycosides controlled by plasma levels in the aged]. Hötter GJ Z Gerontol; 1987; 20(1):8-12. PubMed ID: 3577317 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of congestive heart failure with cardiac glycosides. I. New theses in the principles of treatment]. Tomov I Vutr Boles; 1980; 19(6):7-14. PubMed ID: 7210653 [No Abstract] [Full Text] [Related]
5. [Current data on the role of cardiac glycosides in the treatment of circulatory insufficiency]. Valenkevich LN; Lemkina SM Klin Med (Mosk); 1989 Jan; 67(1):18-23. PubMed ID: 2654460 [No Abstract] [Full Text] [Related]
6. [Comprehensive indication for glycoside therapy from the neurologic-phychiatric viewpoint]. Diehl LW Ther Ggw; 1975 Mar; 114(3):336, 338-40 342-4 PASSIM. PubMed ID: 1092026 [No Abstract] [Full Text] [Related]
7. [Pharmacodynamics, pharmacokinetics and side effects of cardiac glycosides]. Sivkov II; Kukes VG; Ibadova DN; Shokhor VIa; Otdelenov AV Vestn Akad Med Nauk SSSR; 1987; (9):83-7. PubMed ID: 3673236 [No Abstract] [Full Text] [Related]
8. [Drug therapy of cardiovascular diseases. Heart failure. Introduction to the subject. Progress since 1982]. Scholz H Z Kardiol; 1992; 81 Suppl 4():15-6. PubMed ID: 1290292 [No Abstract] [Full Text] [Related]
9. [Cardiac glycoside therapy]. Born H Folia Clin Int (Barc); 1969 Nov; 17(11):534-45. PubMed ID: 5803723 [No Abstract] [Full Text] [Related]
10. [Cardiac glycoside therapy]. Michel D Fortschr Med; 1971 Aug; 89(24):917-21. PubMed ID: 4262966 [No Abstract] [Full Text] [Related]
11. [Experiences with the cardiac glycoside Proscillaridin A (Sandoscill)]. Amirfallah A; Einert HJ Munch Med Wochenschr; 1967 Aug; 109(33):1690-2. PubMed ID: 5631640 [No Abstract] [Full Text] [Related]
12. A preliminary report on a clinical trial of peruvoside--a new cardiac glycoside. Dalal NJ; Billimoria AR; Vakil NJ; Shah SJ Indian Heart J; 1972 Apr; 24(2):129-33. PubMed ID: 4637593 [No Abstract] [Full Text] [Related]
13. [Interaction of cardiac glycosides with other drugs]. Greeff K Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():40-6. PubMed ID: 7187163 [No Abstract] [Full Text] [Related]
14. [Indications and contraindications for therapy with cardiac glycosides]. Haasis R Fortschr Med; 1982 Aug; 100(31-32):1436-9. PubMed ID: 7129303 [TBL] [Abstract][Full Text] [Related]
15. [Changes in the therapy with cardiac glycosides]. Rietbrock N MMW Munch Med Wochenschr; 1982 Jun; 124(22):539-40. PubMed ID: 6808381 [No Abstract] [Full Text] [Related]
16. [The therapy of cardiac insufficiency using Theo-Alvonal]. Kettermann W Munch Med Wochenschr; 1968 Jan; 110(4):228-32. PubMed ID: 5695033 [No Abstract] [Full Text] [Related]
17. [On the therapy of heart insufficiency with the pure glycoside Proscillaridin A]. Lampe W; Tergau G Med Welt; 1966 Apr; 18():1034-9. PubMed ID: 5955405 [No Abstract] [Full Text] [Related]
19. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure. Gold H; Kwit NT; Shane SJ; Dayrit C J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179 [No Abstract] [Full Text] [Related]
20. [Glycoside therapy of cardiac insufficiency in different variants of hemodynamic disorders in children]. Doletskiĭ AS; Apukhtina TE; Timoshchenko OA; Toritsyna IK Pediatriia; 1987; (8):106-7. PubMed ID: 3684422 [No Abstract] [Full Text] [Related] [Next] [New Search]